Cited by 180NF-κB Signaling PathwaysImmune Response and InflammationSignaling Pathways in Disease

ABINs: A20 binding inhibitors of NF-κB and apoptosis signaling

Open access
Verstrepen, Lynn, Carpentier, Isabelle, Verhelst, Kelly, Beyaert, Rudi·2009·Biochemical Pharmacology

Abstract

ABINs have been described as three different proteins (ABIN-1, ABIN-2, ABIN-3) that bind the ubiquitin-editing nuclear factor-kappaB (NF-kappaB) inhibitor protein A20 and which show limited sequence homology. Overexpression of ABINs inhibits NF-kappaB activation by tumor necrosis factor (TNF) and several other stimuli. Similar to A20, ABIN-1 and ABIN-3 expression is NF-kappaB dependent, implicating a potential role for the A20/ABIN complex in the negative feedback regulation of NF-kappaB activation. Adenoviral gene transfer of ABIN-1 has been shown to reduce NF-kappaB activation in mouse liver and lungs. However, ABIN-1 as well as ABIN-2 deficient mice exhibit only slightly increased or normal NF-kappaB activation, respectively, possibly reflecting redundant NF-kappaB inhibitory activities of multiple ABINs. Other functions of ABINs might be non-redundant. For example, ABIN-1 shares with A20 the ability to inhibit TNF-induced apoptosis and as a result ABIN-1 deficient mice die during embryogenesis due to TNF-dependent fetal liver apoptosis. On the other hand, ABIN-2 is required for optimal TPL-2 dependent extracellularly regulated kinase activation in macrophages treated with TNF or Toll-like receptor ligands. ABINs have recently been shown to contain an ubiquitin-binding domain that is essential for their NF-kappaB inhibitory and anti-apoptotic activities. In this context, ABINs were proposed to function as adaptors between ubiquitinated proteins and other regulatory proteins. Alternatively, ABINs might disrupt signaling complexes by competing with other ubiquitin-binding proteins for the binding to specific ubiquitinated targets. Altogether, these findings implicate an important role for ABINs in the regulation of immunity and tissue homeostasis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bcp.2009.02.009

Cites

75 of 75 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The TNIP1 gene product is involved in the inhibition of the TNF-α signaling pathway and nuclear factor κB activation/translocation.

    “For TNIP1, its gene product (TNF-α-induced protein 3-interacting protein 1) is involved in the inhibition of the TNF-α signaling pathway and nuclear factor κB activation/translocation33.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 76 references couldn’t be matched to a known paper.

Research works printed but not linked: 3

  1. Wu CJ, Conze DB, Li T, Srinivasula SM, Ashwell JD. NEMO is a sensor of Lys 63- linked polyubiquitination and functions in NF-kB activation. Nat Cell Biol 2006;8:398-406.
  2. Liu WK, Yen PF, Chien CY, Fann MJ, Su JY, Chou DK. ABIN-2 disrupts the interaction of RIP with IKKg to block NF-kB activation and potentiate apop- tosis. Biochem J 2004;378:867-76.
  3. Heyninck K, Wullaert A, Beyaert R. Nuclear factor-kappaB plays a centrale role in tumour necrosis factor-mediated liver disease. Biochem Pharmacol 2003;66:1409-15.

Cited by

Sorted by citations

Authors
Verstrepen, L., Carpentier, I., Verhelst, K., & Beyaert, R.
Affiliations
Vlaams Instituut voor Biotechnologie (BE)
Corresponding author
Beyaert, Rudi
Venue
Biochemical Pharmacology
Publisher
Elsevier BV
Published
2009-07
Volume
78
Issue
2
Pages
105-114
ISSN
0006-2952 (ISSN-L)
OpenAlex
W2010220327
Cited by
180
References
76
Citations by year
2026: 5 · 2025: 5 · 2024: 7 · 2023: 1 · 2022: 5 · 2021: 6 · 2020: 10 · 2019: 5 · 2018: 16 · 2017: 16 · 2016: 18 · 2015: 11 · 2014: 12 · 2013: 15 · 2012: 12
FWCI
0.94
Type
journal article
Language
en
Open access
Locations
  • Biochemical Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, other-oa)
  • Ghent University Academic Bibliography (Ghent University) (submittedVersion)
  • Trinity's Access to Research Output (TARA) (Trinity College Dublin) (submittedVersion)
Funders
  • Agentschap voor Innovatie door Wetenschap en Technologie
  • Universiteit Gent
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
Keywords
Abin, A20, NF-κB, ubiquitin-binding domain, TNF-induced apoptosis, negative feedback regulation, ERK activation, macrophages, embryonic lethality, immunity, tissue homeostasis, ubiquitinated proteins
MeSH terms
Tumor Necrosis Factor alpha-Induced Protein 3, Amino Acid Sequence, Animals, DNA-Binding Proteins, Humans, Molecular Sequence Data, Nuclear Proteins, Protein Binding, Proteins, Signal Transduction, NF-kappa B, Apoptosis, Intracellular Signaling Peptides and Proteins, Adaptor Proteins, Signal Transducing, Apoptosis Regulatory Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review